Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 27/11/2020
SIETES contiene 93167 citas

 
 
 1 a 15 de 15 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Chang HY, Singh S, Mansour O, Baksh S, Alexander GC. Association between sodium-glucose cotransporter 2 inhibitors and lower extremity amputation among patients with type 2 diabetes. JAMA Intern Med 2018:13 de agosto. [Ref.ID 102824]
2.Enlace a cita original Cita con resumen
Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R. Trends in prescribing of sedative-hypnotic medications in the USA: 1993–2010. Pharmacoepidemiol Drug Saf 2016;25:637-45. [Ref.ID 100393]
3.Tiene citas relacionadas Cita con resumen
Iyer G, Alexander GC. Cardiovascular risks associated with clarithromycin. BMJ 2016;352:i23. [Ref.ID 99980]
4.Tiene citas relacionadas Cita con resumen
Chang H-Y, Zhou M, Tang W, Alexander GC, Singh S. Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study. BMJ 2015;350:h1585. [Ref.ID 98979]
5.Tiene citas relacionadas Cita con resumen
Abraham NS, Singh S, Alexander GC, Heien H, Haas LR, Crown W, Shah ND. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ 2015;350:h1857. [Ref.ID 98978]
6.Enlace a cita original
Fain K, Alexander GC. Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. Pharmacoepidemiol Drug Saf 2013;22:1258-62. [Ref.ID 96649]
7. Cita con resumen
Fain K, Daubresse M, Alexander GC. The Food and Drug Administration Amendments Act and postmarketing commitments. JAMA 2013;310:202-4. [Ref.ID 95794]
8.
Qato DM, Alexander GC. Improving the Food and Drug Administration's mandate to ensure postmarketing drug safety. JAMA 2011;306:1595-6. [Ref.ID 91546]
9.Tiene citas relacionadas
Alexander GC. Seeding trials and the subordination of science. Arch Intern Med 2011;171:1107. [Ref.ID 91331]
10. Cita con resumen
Shah ND, Montori VM, Krumholz HM, Tu K, Alexander GC, Jackevicius CA. Responding to an FDA warning - Geographic variation in the use of rosiglitazone. N Engl J Med 2010;363:2081-4. [Ref.ID 89710]
11.Tiene citas relacionadas Cita con resumen
Dorsey ER, Rabbani A, Gallagher SA, Conti RM, Alexander GC. Impact of FDA black box advisory on antipsychotic medication use. Arch Intern Med 2010;170:96-103. [Ref.ID 87741]
12. Cita con resumen
Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300:2867-78. [Ref.ID 84835]
13. Cita con resumen
Alexander GC, Sehgal NL, Moloney RM, Stafford RS. National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med 2008;168:2088-94. [Ref.ID 84326]
14.
Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006;166:605-9. [Ref.ID 76558]
Seleccionar todas
 
 1 a 15 de 15